Vigabatrin-Induced Visual Field Defects

Abstract

A drug surveillance database at Hoechst Marion Roussel, manufacturers of vigabatrin, identified 92 cases of symptomatic visual field defects associated with vigabatrin (usually as add-on therapy) between 1990 and 1997.

Keywords

• visual field defects
• vigabatrin
• carbamazepine